Screener
Ironwood Pharmaceuticals IRWD Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's other non-current liabilities?
- Ironwood Pharmaceuticals (IRWD) reported other non-current liabilities of $20.54M in Q2 2026.
- How has Ironwood Pharmaceuticals's other non-current liabilities changed year-over-year?
- Ironwood Pharmaceuticals's other non-current liabilities decreased by 8.6% year-over-year, from $22.47M to $20.54M.
- What is the long-term trend for Ironwood Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's other non-current liabilities has grown at a 65.1% compound annual growth rate (CAGR), from $1.76M to $21.65M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Ironwood Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude